Study Evaluating Neratinib Plus Paclitaxel VS Trastuzumab Plus Paclitaxel In ErbB-2 Positive Advanced Breast Cancer
NCT ID: NCT00915018
Last Updated: 2018-08-22
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
479 participants
INTERVENTIONAL
2009-08-21
2018-06-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study Evaluating The Effects Of Neratinib After Adjuvant Trastuzumab In Women With Early Stage Breast Cancer
NCT00878709
Basket Study of Neratinib in Participants With Solid Tumors Harboring Somatic HER2 or EGFR Exon 18 Mutations
NCT01953926
Study Evaluating The Combination Of Neratinib And Capecitabine In Solid Tumors And Breast Cancer
NCT00741260
Comparison of Neoadjuvant Chemotherapy With Weekly Paclitaxel or Eribulin Followed by A/C in Women With Locally Advanced HER2-Negative Breast Cancer
NCT01705691
A Phase 1/2 Study Of HKI-272 (Neratinib) in Combination With Trastuzumab (Herceptin) In Subjects With Advanced Breast Cancer
NCT00398567
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
neratinib plus paclitaxel
Neratinib
Neratinib - 240 mg orally daily, administered once daily. Treatment will be administered until documented disease progression, symptomatic deterioration, unacceptable toxicity, death or withdrawal of consent.
Paclitaxel
Paclitaxel - 80 mg/m² IV administered on days 1, 8, and 15 of a 28-day cycle. Treatment will be administered until documented disease progression, symptomatic deterioration, unacceptable toxicity, death or withdrawal of consent.
trastuzumab plus paclitaxel
Trastuzumab
Trastuzumab - 4 mg/kg IV initial loading dose followed by subsequent once weekly doses of 2mg/kg IV. Treatment will be administered until documented disease progression, symptomatic deterioration, unacceptable toxicity, death or withdrawal of consent.
Paclitaxel
Paclitaxel - 80 mg/m² IV administered on days 1, 8, and 15 of a 28-day cycle. Treatment will be administered until documented disease progression, symptomatic deterioration, unacceptable toxicity, death or withdrawal of consent.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Neratinib
Neratinib - 240 mg orally daily, administered once daily. Treatment will be administered until documented disease progression, symptomatic deterioration, unacceptable toxicity, death or withdrawal of consent.
Trastuzumab
Trastuzumab - 4 mg/kg IV initial loading dose followed by subsequent once weekly doses of 2mg/kg IV. Treatment will be administered until documented disease progression, symptomatic deterioration, unacceptable toxicity, death or withdrawal of consent.
Paclitaxel
Paclitaxel - 80 mg/m² IV administered on days 1, 8, and 15 of a 28-day cycle. Treatment will be administered until documented disease progression, symptomatic deterioration, unacceptable toxicity, death or withdrawal of consent.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Eastern Cooperative Oncology Group (ECOG) 0-2
* Measurable disease
* Availability of tumor tissue for HER2 status confirmation
Exclusion Criteria
* Prior erbB-2 inhibitor other than trastuzumab or lapatinib in the neoadjuvant or adjuvant setting
* Progression/recurrence within 12 months after completion of adjuvant or neoadjuvant therapy
* History of heart disease
* History of gastrointestinal disease
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Puma Biotechnology, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Puma
Role: STUDY_DIRECTOR
Biotechnology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ventura County Hematology-Oncology Specialists
Oxnard, California, United States
Redwood Regional Medical Group
Santa Rosa, California, United States
Cancer Center of Central Connecticut
Plainville, Connecticut, United States
Palm Beach Institute of Hematology and Oncology
Boynton Beach, Florida, United States
North Broward Medical Center Cancer Center
Deerfield Beach, Florida, United States
Broward General Medical Center
Fort Lauderdale, Florida, United States
Mid Florida Cancer Centers
Orange City, Florida, United States
Florida Cancer Research Institute
Plantation, Florida, United States
Hematology Oncology Associates of Treasure Coast
Port Saint Lucie, Florida, United States
Phoebe Cancer Center
Albany, Georgia, United States
Dublin Hematology and Oncology Care
Dublin, Georgia, United States
Clintell
Skokie, Illinois, United States
Presence Hematology and Oncology
Skokie, Illinois, United States
Springfield Clinic
Springfield, Illinois, United States
CHRISTUS St. Frances Cabrini Hospital
Alexandria, Louisiana, United States
Hematology Oncology Services
Metairie, Louisiana, United States
Park Nicollet Institute
Saint Louis Park, Minnesota, United States
Missouri Cancer Associates
Columbia, Missouri, United States
St. John's Medical Research Institute
Springfield, Missouri, United States
Washington University School of Medicine Siteman Cancer Center
St Louis, Missouri, United States
The Valley Hospital, Luckow Pavilion Office of Oncology Clinical Trials
Paramus, New Jersey, United States
Gaston Hematology and Oncology Associates
Gastonia, North Carolina, United States
Summa Health System Hospitals
Akron, Ohio, United States
Warren Cancer Research Foundation
Tulsa, Oklahoma, United States
Samaritan Hematology and Oncology Consultants
Corvallis, Oregon, United States
Pawtucket Memorial Hospital
Pawtucket, Rhode Island, United States
Medical University of South Carolina Hollings Cancer Center
Charleston, South Carolina, United States
Santee Hematology Oncology
Sumter, South Carolina, United States
Tenessee Cancer Specialists
Knoxville, Tennessee, United States
Family Cancer Care
Memphis, Tennessee, United States
Texas Oncology
Bedford, Texas, United States
El Paso Cancer Treatment Center
El Paso, Texas, United States
Texas Oncology-Allison Cancer Center
Midland, Texas, United States
Southlake Oncology
Southlake, Texas, United States
Utah Cancer Specialists
Salt Lake City, Utah, United States
Charleston Area Medical Center, Health, Education, and Research Institute
Charleston, West Virginia, United States
The Queen Elizabeth Hospital
North Adelaide, South Australia, Australia
Royal Melbourne Hospital
Parkville, Victoria, Australia
N.N. Aleksandrov National Cancer Center of Belarus
Lyasny, Minsk Oblast, Belarus
Institution of Healthcare Grodno Regional Clinical Hospital
Grodno, , Belarus
Institution Gomel Regional Clinical Oncology Dispensary
Homyel, , Belarus
Healthcare Institution Vitebsk Regional Clinical Oncology Dispensary
Vitebsk, , Belarus
Institut Jules Bordet
Brussels, , Belgium
District Dispensary for Oncology Diseases Internal Unit- Plovdiv EOOD
Plovdiv, , Bulgaria
District Dispensary for Oncology Diseases Internal Unit- Sofia EOOD
Sofia, , Bulgaria
Specialised Hospital of ActiveTreatment in Oncology, Clinic of Chemotherapy
Sofia, , Bulgaria
Hopital Charles, LeMoyne Le Centre Intégré de Cancérologie de la Montérégie
Greenfield Park, Quebec, Canada
Centre Hospitalier Régional de Trois-Rivières
Trois-Rivières, Quebec, Canada
Sun Yat-Sen University Cancer Center
Guangzhou, Guangdong, China
Southern Medical University Nanfang Hospital
Guangzhou, Guangdong, China
Zhejiang Cancer Hospital
Hangzhou, Zhejiang, China
Cancer Hospital, Chinese Academy of Medical Sciences
Beijing, , China
Peking Union Medical College Hospital of Chinese Academy of Medical Sciences
Beijing, , China
The Hospital Affiliated Academy Military Medical Science, Chinese People's Liberation Army
Beijing, , China
Chinese People's Liberation Army General Hospital
Beijing, , China
Fudan University Shanghai Cancer Center
Shanghai, , China
Tianjin Cancer Hospital
Tianjin, , China
Clinical Hospital Osijek, Department of Radiotherapy and Oncology
Osijek, , Croatia
University Hospital For Tumors
Zagreb, , Croatia
Rigshospitalet, Copenhagen, Onkologisk Klinik
Copenhagen, , Denmark
Hôpital Henri-Mondor
Créteil, , France
Centre Leon Berard Departement de Cancerologie Medicale
Lyon, , France
Centre Val d'Aurelle
Montpellier, , France
Hopital Hotel Dieu, Service d'Oncologie Medicale, Bat B2, 5ieme
Paris, , France
Hopital La Pitie-Salpetriere
Paris, , France
Groupe Hospitalier Paris Saint Joseph, Oncologie medicale
Paris, , France
Service d'Oncologie et de Radiotherapie, Polyclinique Francheville
Périgueux, , France
Clinique Armoricaine de Radiologie
Saint-Brieuc, , France
Centre de Radiothérapie, Clinique Sainte Anne, Service d'Oncologie Libérale
Strasbourg, , France
CHU Strasbourg Departement Oncologie & Hematologie Hopital Civil
Strasbourg, , France
CHU Bretonneau, Centre Henry Kaplan
Tours, , France
Sozialstiftung Bamberg Klinik fuer Haematologie und internistische Onkologie
Bamberg, , Germany
Pamela Youde Nethersole Eastern Hospital
Chai Wan, , Hong Kong
Queen Mary Hospital
Hong Kong, , Hong Kong
UNIMED Medical Institute, Comprehensive Centre for Breast Diseases
Wan Chai, , Hong Kong
Semmelweis Egyetem Radiologiai és Onkoterapias Klinika
Budapest, , Hungary
Fovarosi Onkormanyzat Szent Imre Korhaz Klinikai Onkologiai Profil
Budapest, , Hungary
Orszagos Onkologiai Intezet "B" Belgyogyaszati osztaly
Budapest, , Hungary
Kaposi Mor Oktato Korhoz Onkologiai Centrum
Kaposvár, , Hungary
Bacs-Kiskun Megyei Onkormanyzat Korhaza Onkoradiologiai Kozpont
Kecskemét, , Hungary
Borsod-Abaúj-Zemplén Megyei Kórház és Egyetemi Oktató Kórház
Miskolc, , Hungary
Szegedi Tudomanyegyetem Onkoterapias Klinika
Szeged, , Hungary
Jawaharlal Nehru Cancer Hospital
Bhopal, Madhya Pradesh, India
Tata Memorial Centre
Mumbai, Maharashtra, India
Central India Cancer Research Institute
Nagpur, Maharashtra, India
Curie Manavata Cancer Centre
Nashik, Maharashtra, India
Shatabdi Super Speciality Hospital
Nashilk, Maharashtra, India
Deenanath Mangeshkar Hospital and Research Centre
Pune, Maharashtra, India
Institute Rotary Cancer Hospital, AIIMS
New Delhi, National Capital Territory of Delhi, India
Searoc Cancer Center
Jaipur, Rajasthan, India
Meenakshi Mission Hospital and Research Centre
Madurai, Tamil Nadu, India
B P Poddar and Medical Research Ltd.
Kolkata, West Bengal, India
Kaplan Medical Center
Rehovot, , Israel
Sourasky Medical Center
Tel Aviv, , Israel
Assaf Harofeh Medical Center
Ẕerifin, , Israel
Policlinico di Modena Oncologia ed Ematologia
Modena, , Italy
Fondazione Salvatore Maugeri
Pavia, , Italy
Policlinico Universitario Campus Bio-Medico
Roma, , Italy
Ospedale San Pietro Fatebenefratelli
Roma, , Italy
Ospedale San Giovanni Battista-Molinette
Torino, , Italy
Hyogo Cancer Center
Hyōgo, Akashi-shi, Japan
National Hospital Organization Beppu Medical Center
Ōita, Beppu-shi, Japan
Tokyo Metropolitan Cancer and Infectious Disease Center, Komagome Hospital
Tokyo, Bunkyo-ku, Japan
Chiba Cancer Center
Chiba, Chiba-shi, Japan
National Hospital Organization Kyushu Cancer Center
Fukuoka, Fukuoka-shi, Japan
National Hospital Organization Mito Medical Center
Ibaraki, Higashiibaraki-gun, Japan
Hiroshima University Hospital
Hiroshima, Hiroshima-shi, Japan
Hakuaikai Medical Corporation Sagara Hospital
Kagoshima, Kagoshima-city, Japan
National Cancer Center Hospital East
Chiba, Kashiwa-shi, Japan
Saitama Cancer Center
Saitama, Kitaadachi-gun, Japan
Kumamoto Municipal Hospital
Kumamoto, Kumamoto-city, Japan
Kurume Daiichi Social Insurance Hospital
Fukuoka, Kurume-Shi, Japan
National Hospital Organization Shikoku Cancer Center
Ehime, Matsuyama-city, Japan
Iwate Medical University Hospital
Numakunai, Morioka-shi, Japan
Aichi Cancer Center
Aichi, Nagoya-shi, Japan
National Hospital Organization Nagoya Medical Center
Aichi, Nagoya, Japan
Niigata Cancer Center Hospital
Niigata, Niigata-shi, Japan
Osaka Medical Center for Cancer and Cardiovascular Diseases
Osaka, Osaka-shi, Japan
National Hospital Organization Osaka National Hospital
Osaka, Osaka-shi, Japan
National Hospital Organization Hokkaido Cancer Center
Hokkaido, Sapporo-shi, Japan
Tohoku University Hospital
Miyagi, Sendai-city, Japan
Tenri Hospital
Nara, Tenri-shi, Japan
Kanagawa Cancer Center
Kanagawa, Yokohama-City, Japan
Hiroshima City Hospital
Hiroshima, , Japan
National Hospital Organization Kure Medical Center and Chugoku Cancer Center
Hiroshima, , Japan
Kobe City Medical Center General Hospital
Hyōgo, , Japan
Shinko Hospital
Hyōgo, , Japan
Kumamoto University Hospital
Kumamoto, , Japan
Tazuke Kofukai Medical Research Institute Kitano Hospital
Osaka, , Japan
Osaka University Hospital
Osaka, , Japan
Jichi Medical University Hospital
Tochigi, , Japan
Toranomon Hospital
Tokyo, , Japan
National Hospital Organization Tokyo Medical Center
Tokyo, , Japan
Piejuras Hospital, Liepajas Oncological Clinic
Liepāja, , Latvia
Pauls Stradiņš Clinical University Hospital
Riga, , Latvia
Riga Eastern University Hospital
Riga, , Latvia
Hospital of Lithuanian University of Health sciences
Kaunas, , Lithuania
Nacionalinis Vezio Institutas, Vilniaus Universiteto Onkologijos Institutas
Vilnius, , Lithuania
University Malaya Medical Centre
Kuala Lumpur, , Malaysia
Sir Anthony Oncology Center
Floriana, , Malta
Samodzielny Publiczny Zaklad Opieki Zdrowotnej Szpital Wojewodzki Oddzial
Jelenia Góra, Lower Silesian Voivodeship, Poland
Magodent
Warsaw, Masovian Voivodeship, Poland
Opolskie Centrum Onkologii
Opole, Opole Voivodeship, Poland
Zakład Opieki Zdrowotnej MSW z Warmińsko, Mazurskim Centrum Onkologii
Olsztyn, Warmian-Masurian Voivodeship, Poland
Białostockie Centrum Onkologii
Bialystok, , Poland
Hospital da Luz Servico de Oncologia Medica
Lisbon, , Portugal
Institutul Oncologic Prof. Dr. Ion Chiricuţă
Cluj-Napoca, Cluj, Romania
SC Oncolab S.R.L.
Craiova, Dolj, Romania
Spitalul Universitar de Urgenta Bucuresti
Bucharest, , Romania
Institute of Oncology and Radiology of Serbia
Belgrade, , Serbia
Clinical centre Nis Clinic of Oncology
Niš, , Serbia
National University Hospital, National Cancer Institute
Singapore, , Singapore
National Cancer Centre Singapore
Singapore, , Singapore
GVI Oncology
Port Elizabeth, Eastern Cape, South Africa
The Medical Oncology Centre of Rosebank
Johannesburg, Gauteng, South Africa
University of Witwatersrand Oncology, Donald Gordon Medical Centre
Johannesburg, Gauteng, South Africa
Sandton Oncology Centre
Johannesburg, Gauteng, South Africa
Eastleigh Breast Care Centre
Pretoria, Gauteng, South Africa
Westridge Medical Centre
Durban, KwaZulu-Natal, South Africa
GVI Oncology
Kraaifontein, Western Cape, South Africa
National Cancer Center, Center for Breast Cancer
Goyang-si, Gyeonggi-do, South Korea
Samsung Medical Center
Seoul, Korea, South Korea
Asan Medical Center
Seoul, Korea, South Korea
Korea University Guro Hospital
Seoul, Korea, South Korea
Yonsei University Health System Severance Hospital
Seoul, Seoul/Korea, South Korea
Hospital Son Llàtzer
Palma, Balearic Islands, Spain
Hospital Universitari Arnau de Vilanova
Lleida, Catalonia, Spain
Complejo Hospitalario Universitario Santiago de Compostela
Santiago de Compostela, Galicia, Spain
Hospital Universitario Fundación Alcorcón
Alcorcón, Madrid, Spain
Hospital Puerta De Hierro
Majadahonda, Madrid, Spain
Hospital Universitario Infanta Cristina
Parla, Madrid, Spain
Hospital Madrid Norte Sanchinarro Centro Integral Oncológico Clara Campal Ensayos Clínicos
PAU de Sanchinarro, Madrid, Spain
Hospital Costa del Sol
Marbella, Malaga, Spain
Hospital de Cruces
Barakaldo, Vizcaya, Spain
Centro Oncologico MD Anderson
Madrid, , Spain
Hospital Universitario Ramón y Cajal
Madrid, , Spain
Hospital Universitario 12 de Octubre
Madrid, , Spain
Tumor Center Hirslanden Medical Center
Aarau, , Switzerland
Spital STS AG Onkologiezentrum Thun - Berner Oberland
Thun, , Switzerland
Kantonsspital Winterthur Medizinische Onkologie
Winterthur, , Switzerland
Chang Gung Medical Foundation, Linkou Branch
Taoyuan District, , Taiwan
Affinity Research Limited
Nassau, CB, The Bahamas
Ege Universitesi Tip Fakultesi Tulay Aktas Onkoloji Hastanesi
Bornova, İzmir, Turkey (Türkiye)
Komunalnyy Zaklad Cherkasskyy Oblasnyy Onkologichnyy Dyspanser
Cherkassy, , Ukraine
Chernivtsi Regional Oncology Centre Outpatient Department Bukovynian State Medical University Department of Oncology and Radiology
Chernivtsi, , Ukraine
City Multifield Clinical Hospital
Dnipropetrovsk, , Ukraine
Donetsk Regional Antitumor Center Department of Pretumor Diseases and Tumor Treatment
Donetsk, , Ukraine
S.P. Grigoreva Institute of Medical Radiology Department of Chemotherapy
Kharkiv, , Ukraine
National Institute of Cancer Department of Conseravtive Methods of Treatment
Kyiv, , Ukraine
Volyn Regional Oncological Center
Lutsk, , Ukraine
State Oncological Regional Treatment and Diagnostic Center
Lviv, , Ukraine
Mariupil Oncological Center
Mariupil, , Ukraine
Sumy Regional Clinical Oncology Centre
Sumy, , Ukraine
Guy's and St Thomas NHS Foundation Trust Management Offices 4th Floor Bermondsey Wing Guy's Hospital
London, , United Kingdom
Nottingham University Hospital
Nottingham, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Awada A, Colomer R, Inoue K, Bondarenko I, Badwe RA, Demetriou G, Lee SC, Mehta AO, Kim SB, Bachelot T, Goswami C, Deo S, Bose R, Wong A, Xu F, Yao B, Bryce R, Carey LA. Neratinib Plus Paclitaxel vs Trastuzumab Plus Paclitaxel in Previously Untreated Metastatic ERBB2-Positive Breast Cancer: The NEfERT-T Randomized Clinical Trial. JAMA Oncol. 2016 Dec 1;2(12):1557-1564. doi: 10.1001/jamaoncol.2016.0237.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
3144A2-3005 / B1891005
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.